| Estradiol / progesterone (Bijuve®) for hormone replacement therapy in postmenopausal women |
New Drug Evaluations |
May 2022 |
| Estradiol spray for the treatment of menopausal symptoms |
New Drug Evaluations |
February 2022 |
| Fast acting insulin lispro for the treatment of diabetes mellitus |
New Drug Evaluations |
February 2021 |
| Oral semaglutide for the treatment of type 2 diabetes mellitus |
New Drug Evaluations |
October 2020 |
| Brolucizumab for wet age-related macular degeneration |
New Drug Evaluations |
September 2020 |
| Levodopa inhalation powder for episodic motor fluctuations in Parkinson’s disease |
New Drug Evaluations |
February 2020 |
| Naldemedine for the treatment of opioid induced constipation |
New Drug Evaluations |
November 2019 |
| Pentosan for the treatment of bladder pain syndrome |
New Drug Evaluations |
October 2019 |
| Insulin glargine plus lixisenatide (Suliqua) for the treatment of T2DM |
New Drug Evaluations |
August 2019 |
| Lidocaine/prilocaine spray for premature ejaculation (update) |
New Drug Evaluations |
May 2019 |
